Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 663 | 5,963 | 18,658 | 50,917 | 38,093 |
| Gross Profit | 663 | 5,963 | 18,658 | 50,917 | 38,093 |
| Operating Expenses | 28,594 | 21,731 | 19,944 | 28,296 | 20,414 |
| Operating Income | -27,931 | -15,768 | -1,286 | 22,621 | 17,679 |
| Other Income | 1,476 | 1,597 | 1,195 | 966 | 1,260 |
| Pre-tax Income | -26,455 | -14,171 | -91 | 23,587 | 18,939 |
| Income Tax | 55 | 58 | 63 | 62 | 63 |
| Net Income Continuous | -26,510 | -14,229 | -154 | 23,525 | 18,876 |
| Net Income | $-26,510 | $-14,229 | $-154 | $23,525 | $18,876 |
| EPS Basic Total Ops | -0.33 | -0.09 | 0.00 | 0.27 | 0.22 |
| EPS Basic Continuous Ops | -0.31 | -0.09 | 0.00 | 0.27 | 0.22 |
| EPS Diluted Total Ops | -0.33 | -0.09 | 0.00 | 0.27 | 0.22 |
| EPS Diluted Continuous Ops | -0.31 | -0.09 | 0.00 | 0.27 | 0.22 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.09 | 0.00 | 0.27 | 0.22 |
| EBITDA(a) | $-28,140 | $-16,270 | $-1,336 | $22,552 | $17,305 |